Hematology, Department of Translational and Precision Medicine, Sapienza University, 00161 Rome, Italy.
IRCCS Regina Elena National Cancer Institute, Department of Research, Advanced Diagnostics and Technological Innovation, Clinical Pathology and Cancer Biobank, 00144 Rome, Italy.
Blood Cells Mol Dis. 2023 Mar;99:102721. doi: 10.1016/j.bcmd.2022.102721. Epub 2022 Nov 26.
Multiparametric flow cytometry is an extensively used technique to assess the presence of different cellular populations in immunology and hematology. During routine immunophenotyping analysis, it is not uncommon to face cells of non-hemopoietic origin, negative for CD45 and other myeloid, megakaryocytic, B and T lineage antigens and positive for at least one antibody among CD56, CD117 and CD138. If cytology cannot identify cell origin, especially in cases of unclear interpretation, the contribution of multiparametric flow cytometry analysis can be crucial. We report 6 patients with a clinical suspicion of hematological disease in which multiparametric flow cytometry was extremely useful to quickly exclude blood disorders in order to initiate patients to the most appropriate diagnostic process.
多参数流式细胞术是一种广泛用于评估免疫学和血液学中不同细胞群体存在的技术。在常规免疫表型分析中,遇到非造血来源的细胞并不罕见,这些细胞 CD45 阴性,其他髓系、巨核细胞系、B 细胞和 T 细胞系抗原阴性,但至少有一种 CD56、CD117 和 CD138 抗体阳性。如果细胞学无法确定细胞来源,特别是在解释不清楚的情况下,多参数流式细胞术分析的贡献可能至关重要。我们报告了 6 例临床怀疑为血液疾病的患者,多参数流式细胞术非常有助于快速排除血液疾病,以便为患者启动最合适的诊断过程。